Insilico Medicine, Inc.
ROCKVILLE, MD · Founded 2014 · CIK 0001698493 · Biotech · Public
AI platform for drug discovery and longevity research using generative models and machine learning
insilico.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $20M
- 3 Form D · Jun 2018
- 100 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 23
- 7 granted · 16 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $9,998,988 | |
| Private capital raised | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $5,999,950 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2524 | ASSAYQUANT TECHNOLOGIES, INC. | — | $9.6M |
| 2525 | Sonata Biosciences Inc | — | — |
| 2526 | GENTEL BIOSCIENCES INC | — | $2.7M |
| 2527 | Insilico Medicine, Inc. | — | $20M |
| 2528 | Nuvectis Pharma, Inc. | — | $16M |
| 2529 | ImmuneBridge Inc. | — | $16M |
| 2530 | IpiNovyx Bio, Inc. | — | $7.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- James MellonDirector
- Aleksandrs ZavoronkovsDirector · Executive Officer
- Alex ZhavoronkovDirector · Executive Officer
- Qingsong ZhuExecutive Officer
Patents
- Subset Conditioning Using Variational Autoencoder With A Learnable Tensor Train Induced Priorgranted
- Mutual Information Adversarial Autoencodergranted
- A Method Of Treating Senescence With Multi-stage Longevity Therapeuticsgranted
- Withaferin Compositions For Prevention Of Aginggranted
- Tlr Inhibitorsgranted
- Deep Proteome Markers Of Human Biological Aging And Methods Of Determining A Biological Aging Clockgranted
- Deep Transcriptomic Markers Of Human Biological Aging And Methods Of Determining A Biological Aging Clockgranted
- BRD2 Protein Inhibitor Compounds And Uses Thereofapplication
- Systems, Methods And Software For Ranking Potential Geroprotective Drugsapplication
- System, Method And Software For Robust Transcriptomic Data Analysisapplication
- System, Method, and Software for Improved Drug Efficacy and Safety in a Patientapplication
- System, Method and Software for Improved Drug Efficacy and Safety in a Patientapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.